These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19160521)

  • 1. A-94964, novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. II. Physico-chemical properties and structure elucidation.
    Fujita Y; Murakami R; Muramatsu Y; Miyakoshi S; Takatsu T
    J Antibiot (Tokyo); 2008 Sep; 61(9):545-9. PubMed ID: 19160521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity.
    Murakami R; Fujita Y; Kizuka M; Kagawa T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2008 Sep; 61(9):537-44. PubMed ID: 19160520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-90289 A and B, new inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 60405.
    Fujita Y; Kizuka M; Funabashi M; Ogawa Y; Ishikawa T; Nonaka K; Takatsu T
    J Antibiot (Tokyo); 2011 Jul; 64(7):495-501. PubMed ID: 21587261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-503083 A, B, E and F, novel inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 62799.
    Muramatsu Y; Ohnuki T; Ishii MM; Kizuka M; Enokita R; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2004 Oct; 57(10):639-46. PubMed ID: 15638324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II: physico-chemical properties and structure elucidation.
    Iwatsuki M; Uchida R; Yoshijima H; Ui H; Shiomi K; Kim YP; Hirose T; Sunazuka T; Abe A; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Apr; 61(4):230-6. PubMed ID: 18503202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.
    Muramatsu Y; Muramatsu A; Ohnuki T; Ishii MM; Kizuka M; Enokita R; Tsutsumi S; Arai M; Ogawa Y; Suzuki T; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):243-52. PubMed ID: 12760680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel isoquinoline alkaloid, DD-carboxypeptidase inhibitor, with antibacterial activity isolated from Streptomyces sp. 8812. Part II: Physicochemical properties and structure elucidation.
    Solecka J; Sitkowski J; Bocian W; Bednarek E; Kawecki R; Kozerski L
    J Antibiot (Tokyo); 2009 Oct; 62(10):581-5. PubMed ID: 19713991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. SANK 60206.
    Murakami R; Fujita Y; Kizuka M; Kagawa T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2007 Nov; 60(11):690-5. PubMed ID: 18057698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of metabolites in intact Streptomyces citricolor culture supernatants using high-resolution nuclear magnetic resonance and directly coupled high-pressure liquid chromatography-nuclear magnetic resonance spectroscopy.
    Abel CB; Lindon JC; Noble D; Rudd BA; Sidebottom PJ; Nicholson JK
    Anal Biochem; 1999 Jun; 270(2):220-30. PubMed ID: 10334839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of the uridine-derived nucleoside antibiotic A-94964: identification and characterization of the biosynthetic gene cluster provide insight into the biosynthetic pathway.
    Shiraishi T; Nishiyama M; Kuzuyama T
    Org Biomol Chem; 2019 Jan; 17(3):461-466. PubMed ID: 30570639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.
    Ohnuki T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):268-79. PubMed ID: 12760683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
    Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H; M-1 and M-2.
    Muramatsu Y; Miyakoshi S; Ogawa Y; Ohnuki T; Ishii MM; Arai M; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):259-67. PubMed ID: 12760682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of amipurimycin, a new nucleoside antibiotic produced by Streptomyces novoguineensis.
    Goto T; Toya Y; Kondo T
    Nucleic Acids Symp Ser; 1980; (8):s73-4. PubMed ID: 7255201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radamycin, a novel thiopeptide produced by streptomyces sp. RSP9. II. Physico-chemical properties and structure determination.
    Castro Rodríguez J; González Holgado G; Santamaría Sánchez RI; Cañedo LM
    J Antibiot (Tokyo); 2002 Apr; 55(4):391-5. PubMed ID: 12061547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. II. Structure elucidation.
    Marazzi A; Kurz M; Stefanelli S; Colombo L
    J Antibiot (Tokyo); 2005 Apr; 58(4):260-7. PubMed ID: 15981412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance and biosynthetic studies of neoantimycin and structure elucidation of isoneoantimycin, a minor metabolite related to neoantimycin.
    Takeda Y; Masuda T; Matsumoto T; Takechi Y; Shingu T; Floss HG
    J Nat Prod; 1998 Aug; 61(8):978-81. PubMed ID: 9722479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NW-G01, a novel cyclic hexapeptide antibiotic, produced by Streptomyces alboflavus 313: II. Structural elucidation.
    Guo Z; Ji Z; Zhang J; Deng J; Shen L; Liu W; Wu W
    J Antibiot (Tokyo); 2010 May; 63(5):231-5. PubMed ID: 20379216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albidopyrone, a new alpha-pyrone-containing metabolite from marine-derived Streptomyces sp. NTK 227.
    Hohmann C; Schneider K; Bruntner C; Brown R; Jones AL; Goodfellow M; Krämer M; Imhoff JF; Nicholson G; Fiedler HP; Süssmuth RD
    J Antibiot (Tokyo); 2009 Feb; 62(2):75-9. PubMed ID: 19132055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic GE37468 A: a novel inhibitor of bacterial protein synthesis. II. Structure elucidation.
    Ferrari P; Colombo L; Stella S; Selva E; Zerilli LF
    J Antibiot (Tokyo); 1995 Nov; 48(11):1304-11. PubMed ID: 8557573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.